Wharton's Jelly Mesenchymal Stem Cells: Shaping the Future of Osteoarthritis Therapy with Advancements in Chitosan-Hyaluronic Acid Scaffolds.

Autor: Ghamrawi A; Department of Biology, Faculty of Arts and Sciences, University of Balamand, Tripoli, Lebanon., Basso R; Department of Medical Laboratory Sciences, Faculty of Health Sciences University of Balamand, Beirut, Lebanon., Shakik N; Department of Biology, Faculty of Arts and Sciences, University of Balamand, Tripoli, Lebanon., Haddad L; Department of Medical Laboratory Sciences, Faculty of Health Sciences University of Balamand, Beirut, Lebanon., Nasr Z; Department of Biology, Faculty of Arts and Sciences, University of Balamand, Tripoli, Lebanon., Harmouch C; Department of Biology, Faculty of Arts and Sciences, University of Balamand, Tripoli, Lebanon.
Jazyk: angličtina
Zdroj: Stem cells and development [Stem Cells Dev] 2024 Nov 28. Date of Electronic Publication: 2024 Nov 28.
DOI: 10.1089/scd.2024.0033
Abstrakt: This review explores the potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) in cartilage regeneration and osteoarthritis treatment. It covers key factors influencing chondrogenesis, including growth factors, cytokines, and hypoxia, focusing on precise timing. The effectiveness of three-dimensional cultures and scaffold-based strategies in chondrogenic differentiation is discussed. Specific biomaterials such as chitosan and hyaluronic acid are highlighted for tissue engineering. The document reviews clinical applications, incorporating evidence from animal research and early trials and molecular and histological assessments of chondrogenic differentiation processes. It addresses challenges and strategies for optimizing MSC-derived chondrocyte therapy, emphasizing the immunomodulatory properties of these cells. The review concludes as a comprehensive road map for future research and clinical applications in regenerative medicine.
Databáze: MEDLINE